Abstract
To identify an orally active corticotropin-releasing factor 1 receptor antagonist, a series of 6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidines and their derivatives were designed, synthesized and evaluated. An in vitro study followed by in vivo and pharmacokinetic studies of these heterotricyclic compounds led us to the discovery of an orally active CRF1 receptor antagonist. The results of a structure-activity relationship study are presented.
Copyright © 2011 Elsevier Ltd. All rights reserved.
MeSH terms
-
Animals
-
CHO Cells
-
Cricetinae
-
Dose-Response Relationship, Drug
-
Drug Design
-
Male
-
Maze Learning / drug effects
-
Molecular Structure
-
Pyrazoles / chemical synthesis
-
Pyrazoles / chemistry
-
Pyrazoles / pharmacology*
-
Pyrimidines / chemical synthesis
-
Pyrimidines / chemistry
-
Pyrimidines / pharmacology*
-
Rats
-
Rats, Sprague-Dawley
-
Receptors, Corticotropin-Releasing Hormone / antagonists & inhibitors*
-
Stereoisomerism
-
Structure-Activity Relationship
-
Swine
Substances
-
Pyrazoles
-
Pyrimidines
-
Receptors, Corticotropin-Releasing Hormone